Avoid common mistakes on your manuscript.
Correction to: Current Atherosclerosis Reports (2020)
https://doi.org/10.1007/s11883-020-00858-4
© The Author(s) 2020
Due to errors during galley proofing, the original version of this article has been corrected.
The following errors were corrected: page 4, paragraph 2, line 4, “week 126” is corrected to “week 246”; page 5, paragraph 1, line 2, “LDL” is corrected to “LDL-C”; page 5, paragraph 1, line 5, “absorbed” is corrected to “internalized”; page 6, paragraph 3, column 2, line 5, “from Spain” was corrected to “of an Hispanic female”; page 6, paragraph 5, line 13, “five” was corrected to “six”, and “two” was corrected to “three”; page 7, paragraph 2, line 4, “and no LA” was added after “20 mg/day”; page 7, paragraph 3, line 1, “a single” was corrected to “an”; Figure 1, “12-patient paediatric” should read “11-patient paediatric.” We also have p4 para 2 line 3 where 296 has been changed to 294, and same page, para 3, line 6 where awe have added ‘Risk’ to Risk Management Plan.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s11883-020-00858-4
Rights and permissions
About this article
Cite this article
Stefanutti, C. Correction to: Lomitapide – a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia. Curr Atheroscler Rep 22, 41 (2020). https://doi.org/10.1007/s11883-020-00869-1
Published:
DOI: https://doi.org/10.1007/s11883-020-00869-1